Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bio Techne Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Bio Techne Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Bio Techne Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Bio Techne Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
Bio Techne Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Bio Techne Corp, Medical Equipment, Deal Details 14
Venture Financing 14
Exosome Diagnostics Raises USD60 Million in Series B Financing Round 14
Exosome Diagnostics Raises Additional USD17.6 Million in Series B Financing 16
Exosome Diagnostics Raises USD1.5 Million in Financing Round 17
Advanced Cell Diagnostics Raises USD22 Million in Series C Financing 18
Exosome Diagnostics to Raise USD25 Million in Venture Financing 19
Zephyrus Biosciences Raises USD0.3 Million in Venture Financing 20
Exosome Diagnostics Raises US$27 Million In Series B Financing Round 21
Exosome Diagnostics Raises US$7 Million In Venture Financing 23
Advanced Cell Diagnostics Raises US$12 Million In Series B Financing 24
Exosome Diagnostics Raises USD3 Million in Venture Financing 25
Partnerships 26
Bio-Techne Enters into Agreement with Micropoint 26
Exosome Diagnostics Enters into Agreement with Intezyne 27
Exosome Diagnostics Enters into Agreement with Merck 28
Exosome Diagnostics Enters into Agreement with Amgen 29
Exosome Diagnostics Enters into Agreement with Takeda Pharma 30
Bio-Techne Enters into Agreement with B-MoGen Biotechnologies 31
Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 32
Luminex Enters into Distribution Agreement with Bio-Techne 33
Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 34
Exosome Diagnostics Enters into Agreement with Addario Lung Cancer Medical Institute 35
MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 36
Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 37
Qiagen And Exosome Diagnostics Enter Into Agreement To Develop Diagnostics For Cancer Biomarkers 38
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 39
Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 40
Exosome Diagnostics Enters Into Research Agreement With Mount Sinai Hospital 41
Exosome Diagnostics And Qiagen Enter Into Agreement To Develop Line Of Biofluid Nucleic Acid Kits 42
Exosome Diagnostics Enters Into Co-Development Agreement With Promega For Urine Clinical Sample Concentrator Kit 43
Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 44
Equity Offering 45
Astute Medical Raises USD43 Million in Private Palcement of Shares 45
ProteinSimple Withdraws IPO 46
Acquisition 47
Bio-Techne Acquires Exosome Diagnostics 47
Bio Techne Acquires Trevigen 48
Bio-Techne Acquires Advanced Cell Diagnostics 49
Bio-Techne Acquires Space Import-Export for USD9 Million 51
Bio-Techne Acquires Cliniqa 52
Bio-Techne Acquires Cyvek 53
Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 54
Techne Completes Acquisition Of Bionostics For US$104 Million 56
Bio Techne Corp – Key Competitors 58
Bio Techne Corp – Key Employees 59
Bio Techne Corp – Locations And Subsidiaries 60
Head Office 60
Other Locations & Subsidiaries 60
Recent Developments 62
Financial Announcements 62
Aug 07, 2018: Bio-Techne releases fourth quarter fiscal 2018 results 62
May 02, 2018: Bio-Techne Releases Third Quarter Fiscal 2018 Results 65
Feb 06, 2018: Bio-Techne Reports Net Sales Of $154.2 million In The Second Quarter Of Fiscal 2018 67
Oct 31, 2017: Bio-Techne Releases First Quarter Fiscal 2018 Results 69
Aug 08, 2017: Bio-Techne Releases Fourth Quarter Fiscal 2017 Results 71
May 02, 2017: Bio-Techne Releases Third Quarter Fiscal 2017 Results 74
Feb 07, 2017: Bio-Techne Releases Second Quarter Fiscal 2017 Results 76
Corporate Communications 78
Apr 24, 2018: Bio-Techne Appoints Kim Kelderman As President, Diagnostics and Genomics 78
Oct 26, 2017: Bio-Techne Adds Two New Directors to Its Board 79
Product News 80
Jun 26, 2018: Bio-Techne Expands RNAscope Assay Services Portfolio to Shorten Development Times and Save Costs 80
Mar 14, 2018: Bio-Techne Launches MimEX GI, an Accessible 3-D Cell Culturing Platform for the Gastrointestinal Tract 81
Nov 20, 2017: Bio-Techne Offers Updated Novus Panel Builder, Facilitating Multicolor Flow Cytometry Panel Design 82
Other Significant Developments 83
Mar 21, 2018: Bio-Techne has expanded the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) technology with the launch of several new and updated assays 83
Jan 30, 2018: Bio-Techne’s Ella Added to BioAgilytix Portfolio of Industry-Leading Immunoassay Platforms 84
Jan 15, 2018: Advanced Immunolabeling Reagents and Tools from Vector Laboratories Now from Bio-Techne 85
Jan 11, 2017: COPD Biomarker Qualification Consortium Partners with Bio-Techne to Identify COPD Indicator 86
Appendix 87
Methodology 87
About GlobalData 87
Contact Us 87
Disclaimer 87
Bio Techne Corp, Medical Equipment, Key Facts, 2018 2
Bio Techne Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bio Techne Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Bio Techne Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Bio Techne Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Bio Techne Corp, Deals By Market, 2012 to YTD 2018 10
Bio Techne Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Exosome Diagnostics Raises USD60 Million in Series B Financing Round 14
Exosome Diagnostics Raises Additional USD17.6 Million in Series B Financing 16
Exosome Diagnostics Raises USD1.5 Million in Financing Round 17
Advanced Cell Diagnostics Raises USD22 Million in Series C Financing 18
Exosome Diagnostics to Raise USD25 Million in Venture Financing 19
Zephyrus Biosciences Raises USD0.3 Million in Venture Financing 20
Exosome Diagnostics Raises US$27 Million In Series B Financing Round 21
Exosome Diagnostics Raises US$7 Million In Venture Financing 23
Advanced Cell Diagnostics Raises US$12 Million In Series B Financing 24
Exosome Diagnostics Raises USD3 Million in Venture Financing 25
Bio-Techne Enters into Agreement with Micropoint 26
Exosome Diagnostics Enters into Agreement with Intezyne 27
Exosome Diagnostics Enters into Agreement with Merck 28
Exosome Diagnostics Enters into Agreement with Amgen 29
Exosome Diagnostics Enters into Agreement with Takeda Pharma 30
Bio-Techne Enters into Agreement with B-MoGen Biotechnologies 31
Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 32
Luminex Enters into Distribution Agreement with Bio-Techne 33
Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 34
Exosome Diagnostics Enters into Agreement with Addario Lung Cancer Medical Institute 35
MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 36
Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 37
Qiagen And Exosome Diagnostics Enter Into Agreement To Develop Diagnostics For Cancer Biomarkers 38
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 39
Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 40
Exosome Diagnostics Enters Into Research Agreement With Mount Sinai Hospital 41
Exosome Diagnostics And Qiagen Enter Into Agreement To Develop Line Of Biofluid Nucleic Acid Kits 42
Exosome Diagnostics Enters Into Co-Development Agreement With Promega For Urine Clinical Sample Concentrator Kit 43
Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 44
Astute Medical Raises USD43 Million in Private Palcement of Shares 45
ProteinSimple Withdraws IPO 46
Bio-Techne Acquires Exosome Diagnostics 47
Bio Techne Acquires Trevigen 48
Bio-Techne Acquires Advanced Cell Diagnostics 49
Bio-Techne Acquires Space Import-Export for USD9 Million 51
Bio-Techne Acquires Cliniqa 52
Bio-Techne Acquires Cyvek 53
Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 54
Techne Completes Acquisition Of Bionostics For US$104 Million 56
Bio Techne Corp, Key Competitors 58
Bio Techne Corp, Key Employees 59
Bio Techne Corp, Subsidiaries 60
List of Figures
Bio Techne Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bio Techne Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bio Techne Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bio Techne Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bio Techne Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Bio Techne Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
Bio Techne Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Bio Techne Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 10